NRX Pharmaceuticals, Inc (NRXP)

Sector:
FINANCE
Industry:
CORPORATE FINANCE
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Stephen H. Willard
Employees:
1201 N. MARKET STREET, SUITE 111, WILMINGTON, DE, 19801
484-254-6134

NRX Pharmaceuticals, Inc. develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure.

Data derived from most recent annual or quarterly report
Market Cap 18.843 Million Shares Outstanding70.31 Million Avg 30-day Volume 1.57 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-0.12
Price to Revenue67.1777 Debt to Equity-5.5851 EBITDA-36.122 Million
Price to Book Value0.0 Operating Margin0.0 Enterprise Value36.117 Million
Current Ratio EPS Growth0.525 Quick Ratio
1 Yr BETA 0.4195 52-week High/Low 1.54 / 0.22 Profit Margin-7415.5598
Operating Cash Flow Growth41.2256 Free Cash Flow to Firm (FCFF) TTM -9.733 Million Free Cash Flow to Equity (FCFE) TTM-14.392 Million
Altman Z-Score
Earnings Report2023-11-13
View SEC Filings from NRXP instead.

View recent insider trading info

NRX Pharmaceuticals, Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NRXP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NRXP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

405 Thousand total shares from 4 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

NARIDO RICHARD CLAVANO INTERIM CFO

  • Officer
 0 2023-09-13 1

HURVITZ CHAIM

  • Director
 2,214,793 2023-08-30 3

GOROVITZ AARON

  • Director
 105,000 2023-08-30 2

JAVITT JONATHAN C CHIEF SCIENTIST

  • Officer
  • Director
  • 10% Owner
 14,768,329 2023-08-23 4

VAN VOORHEES SETH CHIEF FINANCIAL OFFICER

  • Officer
 46,337 2022-12-16 3

WILLARD STEPHEN H CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
 50,000 2022-12-16 1

JAVITT DANIEL C.

  • 10% Owner
 9,634,793 2022-11-29 3

FLYNN PATRICK JOHN

  • Director
 82,168 2022-11-28 2

GLIED SHARON

  • Director
 228,097 2022-10-21 1

STRASSBERG IRA S CHIEF FINANCIAL OFFICER

  • Officer
 0 2022-03-15 0

BESTHOF ROBERT INTERIM CEO

  • Officer
 347,200 2022-03-08 0

MCMASTER HERBERT RAYMOND

  • Director
 45,086 2021-08-26 0

DAIGNEAULT ALESSANDRA GENERAL COUNSEL & SECRETARY

  • Officer
 316,205 2021-08-19 0

TROY DANIEL

  • Director
 0 2021-05-24 0

BIG ROCK PARTNERS SPONSOR, LLC

ACKERMAN RICHARD PRESIDENT & CEO

  • Officer
  • Director
  • 10% Owner
 No longer subject to file 2021-05-24 0

FRICKER WILLIAM CFO & TREASURER

  • Officer
 0 2021-05-24 0

BRAC LENDING GROUP LLC

  • 10% Owner
 No longer subject to file 2021-05-24 0

TAYLOR TROY T

  • Director
 0 2017-11-20 0

KOENIG STUART F.

  • Director
 0 2017-11-20 0

WITTMAN LORI CFO

  • Officer
  • Director
 0 2017-11-20 0

KIM BENNETT CHIEF INVT. OFC. & CORP. SEC.

  • Officer
 0 2017-11-20 0

BIRDOFF RICHARD

  • Director
 0 2017-11-20 0

FONG MICHAEL

  • Director
 0 2017-11-20 0

REX ALBERT G.

  • Director
 0 2017-11-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HURVITZ CHAIM - Director

2023-09-11 09:15:13 -0400 2023-08-30 P 70,000 $0.29 a 570,000 direct -0.3817 -1.9084 8.7786 5 -3.4351 3

GOROVITZ AARON - Director by spouse

2023-09-11 09:19:33 -0400 2023-08-30 P 35,000 $0.32 a 105,000 indirect -0.3817 -1.9084 8.7786 5 -3.4351 3

JAVITT JONATHAN C - Director - Officer - > 10% Owner CHIEF SCIENTIST

2023-08-24 12:14:01 -0400 2023-08-23 P 100,000 $0.33 a 446,332 direct -5.8824 -13.2353 0.0 1 -13.2353 6

JAVITT JONATHAN C - Director - Officer - > 10% Owner CHIEF SCIENTIST

2023-08-23 09:24:41 -0400 2023-08-22 P 200,000 $0.32 a 346,332 direct 19.7183 11.6197 19.7183 2 0.0 1

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
NRX PHARMACEUTICALS INC NRXP 2023-09-29 22:15:03 UTC -7.7909 13.1109 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 21:45:04 UTC -7.7909 13.1109 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 21:15:03 UTC -7.7909 13.1109 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 20:45:05 UTC -7.7909 13.1109 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 20:15:04 UTC -7.7909 13.1109 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 19:45:04 UTC -7.7909 13.1109 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 19:15:03 UTC 0.0 0.0 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 18:45:03 UTC 0.0 0.0 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 18:15:03 UTC 0.0 0.0 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 17:45:03 UTC -7.7909 13.1109 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 17:15:04 UTC -7.7909 13.1109 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 16:45:04 UTC -7.0774 12.3974 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 16:15:03 UTC -7.0774 12.3974 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 15:45:04 UTC -7.0774 12.3974 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 15:15:04 UTC -7.0774 12.3974 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 14:45:04 UTC -7.0774 12.3974 250000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 14:15:04 UTC -7.0774 12.3974 200000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 13:45:03 UTC -7.7256 13.0456 200000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 13:15:04 UTC -7.7256 13.0456 200000
NRX PHARMACEUTICALS INC NRXP 2023-09-29 12:45:05 UTC -7.7256 13.0456 200000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments